PGNY - NASDAQ
Progyny, Inc.
$24.99
-4.6%Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
At a Glance
Live SnapshotProgyny, Inc. Management Team
Mr. Peter Anevski CPA
Chief Executive Officer & Director
Compensation
$1,361,112
Mr. Mark S. Livingston CPA
Chief Financial Officer
Compensation
$722,090
Ms. Cassandra Pratt
Chief Human Resources Officer
Ms. Risa Fisher
Chief Marketing Officer
Ms. Melissa B. Cummings
Chief Operating Officer
Mr. Steven Leist
Chief Technology Officer
Mr. David J. Schlanger J.D.
Executive Chairman
Compensation
$468,168
Ms. Allison Swartz
Executive Vice President, General Counsel & Secretary
Compensation
$515,849
Mr. Michael Sturmer
President
Compensation
$867,514
Mr. James Hart
Vice President of Investor Relations
Progyny, Inc. Insider Positioning
During the last 12 months, insiders have purchased $1.93M and sold $1.56M worth of PGNY shares, resulting in $367K of net buying activity.
3 Months
0
0.00
25.8K
648.96K
-649K
-$649K
3-6 Months
0
0.00
3.8K
68.88K
-69K
-$69K
6-9 Months
79.5K
1.93M
34.3K
838.52K
+1.1M
+$1.09M
9-12 Months
0
0.00
339
7.98K
-8K
-$8K
Top Buyers
Anevski Peter
Director, Officer: Chief Executive Officer
$1.93M
Top Sellers
Livingston Mark S.
Officer: Chief Financial Officer
$771K
Cummings Melissa B
Officer: Chief Operating Officer
$239K
Swartz Allison
Officer: Evp, Gc
$204K
Anevski Peter
Director, Officer: Chief Executive Officer
$172K
Gordon Kevin K
Director
$137K
Insider Activity Analysis
Net Insider Sentiment
Moderately bullish with $367K net buying. Insiders show cautious optimism through measured share purchases.
Buy/Sell Ratio
Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Balanced insider activity: Roughly equal buying and selling suggests normal portfolio management rather than strong directional signals. Look to other metrics for clearer investment insights.
SEC Filings
PGNY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 10, 2026 | May 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 11, 2025 | April 11, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 12, 2024 | April 12, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 14, 2023 | April 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 14, 2022 | May 25, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 22, 2021 | June 02, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 22, 2020 | June 02, 2020 | 2020 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.